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Abstract 
Objective: To analyze the use of continued-use medications by Brazilian children with microcephaly caused 
by Congenital Zika Virus Infection. Material and Methods: Cross-sectional study with 76 children of both 
genders. Information on age, use of continued-use medications, number and type of drugs used was 
collected. Data were analyzed using descriptive statistics. Results: Continued-use medications were used by 
89.4% of the children, anticonvulsants / antiepileptics (88.1%), and those indicated for behavioral disorders 
(27.1%) were the most frequent. Sodium saccharin, sucrose, and sorbitol are the most common sugars in the 
composition of these drugs. Conclusion: The use of medicines is high, predominantly anticonvulsants and 
antiepileptics, which contain sugars in their composition. These drugs can lead to irreversible dental 
problems, such as tooth decay if proper oral hygiene is not present. Therefore, parents/guardians should be 
advised about adopting healthy oral hygiene habits after the administration of these drugs. 
 
Keywords: Microcephaly; Child; Prescription Drugs; Oral Health.
 Pesqui. Bras. Odontopediatria Clín. Integr. 2020; 20:e5565 
 
2 
Introduction 
The first description of the Zika virus was made in Uganda in 1947 in the Zika Valley. It is a mild 
disease with fever, erythema, and arthralgia [1]. As there is no known medical treatment for this disease, a 
serious attempt has been needed to eradicate the mosquito and prevent the spread of the disease to other 
Brazilian states and across the border [2]. 
According to the National Institute of Neurological Disorders and Stroke (NINDS), “microcephaly is a 
medical condition in which the circumference of the head is smaller than normal because the brain has not 
developed properly or has stopped growing” [3]. Microcephaly can be present at birth or it may develop in the 
first few years of life [4]. 
In Brazil, “thousands of cases of infants with suspected microcephaly or other developmental 
anomalies of the central nervous system that may be associated with ZIKV infection have been reported” [5]. 
Paraíba is the state with the second-highest number of suspected cases of microcephaly. Most of those were 
born into low-income families that reported difficulties in accessing medicine and attention from the public 
health system [6]. 
There are several studies that warn of the deleterious effects of drugs on primary teeth, due to the 
presence of sugars in the composition of these drugs [7-9]. This study aimed to describe the usage of 
continued-use drugs by children with microcephaly caused by congenital zika syndrome (CZS) and the possible 
implications for oral health. 
 
Material and Methods 
Design and Study Location 
This cross-sectional study was conducted in the city of Campina Grande, State of Paraíba, 
northeastern Brazil. The research was developed in one rehabilitation center that offers assistance to children 
with congenital zika syndrome, providing physical, intellectual, auditory and visual rehabilitation treatment. 
 
Sampling 
The sample consisted of 76 children with confirmed diagnosis of microcephaly of both sexes, attended 
at the Specialized Center for Rehabilitation. 
 
Data Collection 
Through a questionnaire, information was collected by two researchers from September 2016 to April 
2017 regarding the demographic situation and continued-use medicine treatments. 
 
Data Analysis 
Data were organized and analyzed with Statistical Package for Social Sciences, Version 21.0 (IBM 
Corporation, Chicago, IL, USA) using descriptive statistics. 
 
Ethical Aspects 
This study was approved by the Human Research Ethics Committee of the State University of Paraíba 
in compliance with Brazilian National Health Council Resolution 466/12. All parents received information 
 Pesqui. Bras. Odontopediatria Clín. Integr. 2020; 20:e5565 
 
3 
regarding the objectives of the study and provided written informed consent regarding their child’s 
participation. 
 
Results 
Most of the children were female (53.9%), aged between 13 and 24 months (81.6%). The average age 
was 21.1 months (SD ± 4.8), minimum of 8 months, and a maximum of 38 months. 
Continued-use medications were confirmed in 85.9% of the children, with most using only one 
medication (41.0%). The average medication per child was 1.7 (± 1.2). The most commonly used medications 
were Anticonvulsant/Antiepileptic (85.9%) (Table 1). 
 
Table 1. Distribution of children according to continued-use medication 
and type of substance. 
Variables N % 
Sex   
Male 35 46.1 
Female 41 53.9 
Age (in months)   
Up to 12 4 5.3 
13 to 24 62 81.6 
25 to 38 10 13.2 
Continued-use Medications   
Yes 61 85.9 
No 10 14.1 
Number of Medications Utilized   
1 25 41.0 
2 21 34.4 
3 8 13.1 
4 5 8.2 
5 2 3.3 
Type of Medication Utilized   
Anticonvulsant/Antiepileptic   
Yes 53 86.9 
No 8 13.1 
Antispastic   
Yes 16 26.2 
No 45 73.8 
Sedative/Anxiolytic   
Yes 6 9.8 
No 55 90.2 
Behavior Disorder   
Yes 16 26.2 
No 45 73.8 
 
Table 2 presents the composition and possible oral implications of the medications used. Among the 
sugars/sweeteners are sodium saccharin, sucrose, and sorbitol. Other substances, such as cornstarch and 
essences, are also present. As for the oral implications described in the leaflets are dry mouth, vomiting, 
dysgeusia, changes in taste, trismus and sialorrhea. Of particular note are the complications from using an anti-
epileptic drug for children over 1 month of age: swelling of the lips, throat or mouth; difficulty speaking or 
swallowing; blisters on the mucous membranes of the lips and mouth; mouth ulcers and vomiting. 
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Table 2. Distribution of the medications according to composition, class and oral implications. 
Commercial 
Name 
Active Principle Composition Drug Class Form Manufacturer Oral 
Implications 
Pediatric 
Use 
Baclon Baclofen Starch, Lactose 
Monohydrate 
Antispastic Tablet Genomma Lab. Myalgias, Dry Mouth, 
Vomiting, Dysgeusia 
No 
Baclofen Baclofen Starch, Lactose Antispastic Tablet Laboratório Teuto 
Brasileiro S.A 
- No 
Rivotril Clonazepam Lactose, Corn Starch Anxiolytic Tablet Roche Dysarthria Yes 
Tegretol Carbamazepine Caramel Flavor, Sodium 
Saccharin Dihydrate, 
Sorbitol 
Antiepileptics Tablet Medley Changes in Taste, Disjointed 
Speech 
Yes 
Frisium, 
Urbanil 
Clobazam Corn Starch, Lactose 
Monohydrate 
Anxiolytic Tablet Sanofi - Yes, above 3 years 
of age 
Depakene Valproic Acid Sacarose, Sorbitol Anticonvulsant Oral Solution Abbott Laboratórios Vomiting Yes, preferentially 
above 2 years of age 
Fenoarbital Phenobarbital Lactose Monohydrate, 
Amido 
Anticonvulsant Tablet Teuto Difficulty Speaking No 
Gardenal Phenobarbital Sodium Saccharin 
Dihydrate, 
Raspberry Essence 
Anticonvulsant Oral Solution 
(Drops) 
Sanofi Difficulty Speaking Yes, oral pediatric 
use 
Keppra Levetiracetam - Antiepileptic Tablet Biopharma Myalgias Yes, above 6 years 
of age 
Lamictal Lamotrigine Starch, Sodium Starch 
Glycolate 
Antiepileptic Tablet Teuto Vomiting Yes, above 12 years 
of age 
Neuleptil Periciazine Liquid Sucrose, Caramel, 
Mint Essence 
Antipsychotic Oral Solution Sanofi Dry Mouth, Trismus Yes, above 3 years 
of age 
Sabril Vigabatrin Sodium Starch Glycolate Antiepileptic Tablet Sanofi Aventis Vomiting Yes 
Sonebon Nitrazepam Lactose Monohydrate, 
Aluminum Red Lacquer 
Erythrosine 3 
Sedative 
Hypnotic 
Tablet Ems Sigma Pharma 
Ltda 
Dysarthria, Sialorrhea, 
Vomiting, Dry Mouth 
No 
Tegretol Carbamazepine Sorbitol, Sodium 
Saccharin, Caramel 
Flavor 
Anticonvulsant Oral Suspension Novartis Speech Disorders Yes 
Topamax Topiramate Lactose Monohydrate, 
Starch, Sodium Starch 
Glycolate 
Anticonvulsant Tablet Sandoz Increased Salivation, Speech 
Disorders 
Yes 
Trileptal Oxcarbazepine - Antiepileptics Tablet Novartis Swelling of the Lips, Throat or 
Mouth, Difficulty Speaking or 
Swallowing, Blisters on the 
Mucous Membranes of the lips 
and Mouth, Mouth Ulcers, 
Vomiting 
Yes, above 1 month 
of age 
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Discussion 
In most cases of microcephaly, there is severe neurological damage that can result in impaired 
cognition and motor coordination. Therefore, episodes of epileptic seizures and mood swings are common, 
leading children with microcephaly, even at an early age, to use continued-use medications [10]. 
Children with special needs are mostly dependent on their caregivers for their daily living activities 
[9,11], including tooth brushing. Parents and/or caregivers of children with microcephaly have an intense 
routine of therapies, which often occur in different places and may compromise the persistence and routine 
necessary to perform oral hygiene [12]. Added to this is the low age of most of the children in this study 
(81.6% of them were 13 to 24 months old), which can potentiate these oral hygiene difficulties. 
Children with microcephaly have delayed eruption chronology, altered tooth eruption sequence [12-
14], altered muscle tone, with consequences for suction, swallowing, lip seal, and mouth breathing [9]. 
Literature has also mentioned a higher prevalence of enamel defects, which entails a higher risk of dental caries 
[13]. 
Analysis of the drug leaflets revealed that anticonvulsants and antiepileptics, the class of drugs most 
commonly administered by the children in the study, can cause vomiting. At these times, intrinsic acids in the 
organism, present in the gastric juice, are taken to the oral cavity through the atypical flow of content from the 
stomach [15], and this is responsible for making the dental surface soft and susceptible to abrasion and friction 
wear [16]. Because of the higher risk of dental erosion development in these cases, the constant monitoring of 
the children who use this type of medication by a dentist is recommended. 
Special attention is advised to possible oral symptoms resulting from the use of Trileptal®, an 
antiepileptic medicine that, in addition to inducing vomiting, may cause swelling of the lips, throat or mouth, 
difficulty to speak or swallow, blistering of mucous membranes of the lips and mouth, and mouth ulcers, which 
can negatively affect the quality of life of these children. 
More than half of the children use more than one drug, possibly due to the number of sequelae 
resulting from neurological damage, such as visual alterations, speech and hearing disorders, hypertonia, 
intracranial calcifications, choroid plexus enlargement, ventriculomegaly, and hydrocephalus [13]. Therefore, 
it is cautioned that undesirable oral effects may be added to children exposed to more than one drug. 
Most pediatric drugs contain high levels of sucrose [7,9]. The analysis of the leaflets reveals that this 
substance is present in the composition of the medications administered to the children in this study. The 
addition of sucrose improves palatability, favoring acceptance and continuity of the children; sucrose also has 
preservative, antioxidant, solvent and thickening properties [17]. Children who use this substance are exposed 
to a cumulative harmful effect, which can manifest as carious lesions [18]. 
Recommendation to immediately rinse in water and delay tooth-brushing after ingestion of syrup 
medications could be proposed at the time of prescription. Previous authors reported that “medicine labels 
should also alert in relation to the possibility of causing dental caries and erosion since many products could be 
consumed for prolonged periods, several times a day, at bedtime, and without adequate oral hygiene, which 
would certainly contribute to dental caries and erosion” [19]. 
Microcephaly is a condition that causes numerous problems in children's health; so knowing which 
medications are used is extremely relevant. Therefore, dentists should be aware of sugars in child medicine and 
the parents should be informed of the need for proper oral hygiene after medication administration. 
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Conclusion 
The use of medicines that contain sugars in their composition is high, predominantly anticonvulsants 
and antiepileptics. These drugs can lead to irreversible dental problems, such as tooth decay if proper oral 
hygiene is not present. Therefore, parents/guardians should be advised about adopting healthy oral hygiene 
habits after the administration of these drugs. 
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